Reports
Reports
As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
Sale
The global nootropics market attained USD 2 billion in 2020. The global nootropics industry is expected to grow at a CAGR of 14.6% in the forecast period of 2021-2026 to attain USD 5 billion by 2026.
North America has the highest number of nootropics consumers regionally and holds the major market share of nootropics. The U.S. Food and Drug Administration has classified non-prescription nootropics product under the Generally Regarded as Safe (GRAS) category, thereby easing market expansion. Hence, it is the home of the largest market players in the nootropics industry. Consumption of multi-vitamin tablets for improving functional abilities is fairly common among the population of this region. High awareness for cognitive health, the rise of self-directed buyers, and a growing population are some of the factors that drive the market dominance of North America. The Asia Pacific is expected to be the fastest growing market in the forecast period. Countries such as China and India have a great history of cognitive based natural drugs. Foreign investment in collaboration with regional players holds immense potential for the growth of the nootropics industry.
Nootropics are drugs or supplements that claim to improve cognitive function, specifically executive functions, memory, creativity, or motivation, in healthy individuals. These have been in the market for several decades, such as caffeine and multivitamins - substances approved by FDA as dietary supplements and classified as GRAS (generally regarded as safe). Currently, these products are being marketed and sold to academic and professional overachievers to augment their brain functions.
The market is bifurcated by type into:
The market is segmented on the basis of distribution channel into:
The market is segregated on the basis of application into:
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Due to a highly competitive and challenging work environment, the market for brain boosters has witnessed a rise and is expected to grow in the forecast period. The rising demand for improved decision making in the sports industry and growing awareness with respect to mental health are also boosting the rise of the market for nootropics. Due to increasing awareness, rising disposable incomes, and increased demand for productivity, the market is expected to grow rapidly in emerging countries such as China and India. As cognitive enhancers made from natural and herbal substances have already been common in these areas historically, mergers between foreign and local companies are expected to push the market for nootropics in these areas forward. However, on the flip side, various side effects, addiction, lack of awareness, the stigma around visiting psychiatrists and neurologists in developing countries might impede the growth of the nootropics industry.
The report gives a detailed analysis of the following key players in the global nootropics market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model along with giving a SWOT analysis.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Nootropics Market Analysis
8.1 Key Industry Highlights
8.2 Global Nootropics Historical Market (2016-2020)
8.3 Global Nootropics Market Forecast (2021-2026)
8.4 Global Nootropics Market by Type
8.4.1 Prescription
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2016-2020)
8.4.1.3 Forecast Trend (2021-2026)
8.4.2 OTC
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2016-2020)
8.4.2.3 Forecast Trend (2021-2026)
8.5 Global Nootropics Market by Distributional Channel
8.5.1 Online
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2016-2020)
8.5.1.3 Forecast Trend (2021-2026)
8.5.2 Offline
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2016-2020)
8.5.2.3 Forecast Trend (2021-2026)
8.6 Global Nootropics Market by Application
8.6.1 Mood and Depression
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2016-2020)
8.6.1.3 Forecast Trend (2021-2026)
8.6.2 Longevity and Anti-Ageing
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2016-2020)
8.6.2.3 Forecast Trend (2021-2026)
8.6.3 Sleep and Recovery
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2016-2020)
8.6.3.3 Forecast Trend (2021-2026)
8.6.4 Memory Enhancement
8.6.4.1 Market Share
8.6.4.2 Historical Trend (2016-2020)
8.6.4.3 Forecast Trend (2021-2026)
8.6.5 Attention and Focus
8.6.5.1 Market Share
8.6.5.2 Historical Trend (2016-2020)
8.6.5.3 Forecast Trend (2021-2026)
8.6.6 Anxiety
8.6.6.1 Market Share
8.6.6.2 Historical Trend (2016-2020)
8.6.6.3 Forecast Trend (2021-2026)
8.6.7 Others
8.7 Global Nootropics Market by Region
8.7.1 Market Share
8.7.1.1 North America
8.7.1.2 Europe
8.7.1.3 Asia Pacific
8.7.1.4 Latin America
8.7.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2016-2020)
9.1.2 Forecast Trend (2021-2026)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2016-2020)
9.2.2 Forecast Trend (2021-2026)
9.2.3 Breakup by Country Kingdom
9.2.3.1 United
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2016-2020)
9.3.2 Forecast Trend (2021-2026)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2016-2020)
9.4.2 Forecast Trend (2021-2026)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2016-2020)
9.5.2 Forecast Trend (2021-2026)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 EMR’s Key Indicators for Demand
10.4 EMR’s Key Indicators for Price
11 Value Chain Analysis
12 Price Analysis
12.1 North America Historical Price Trends (2016-2021) and Forecast (2021-2026)
12.2 Europe Historical Price Trends (2016-2021) and Forecast (2021-2026)
12.3 Asia Pacific Historical Price Trends (2016-2021) and Forecast (2021-2026)
12.4 Latin America Historical Price Trends (2016-2021) and Forecast (2021-2026)
12.5 Middle East and Africa Historical Price Trends (2016-2021) and Forecast (2021-2026)
13 Competitive Landscape
13.1 Market Structure
13.2 Company Profiles
13.2.1 Purelife Bioscience Co., Ltd.
13.2.1.1 Company Overview
13.2.1.2 Product Portfolio
13.2.1.3 Demographic Reach and Achievements
13.2.1.4 Certifications
13.2.2 UCB S.A.
13.2.2.1 Company Overview
13.2.2.2 Product Portfolio
13.2.2.3 Demographic Reach and Achievements
13.2.2.4 Certifications
13.2.3 HVMN Inc.
13.2.3.1 Company Overview
13.2.3.2 Product Portfolio
13.2.3.3 Demographic Reach and Achievements
13.2.3.4 Certifications
13.2.4 Gaia Herbs, Inc.
13.2.4.1 Company Overview
13.2.4.2 Product Portfolio
13.2.4.3 Demographic Reach and Achievements
13.2.4.4 Certifications
13.2.5 Others
14 Industry Events and Developments
Additional Customisations Available
1 Manufacturing Process
1.1 Overview
1.2 Detailed Process Flow
1.3 Operation Involved
2 Project Requirement and Cost Analysis
2.1 Land, Location and Site Development
2.2 Construction
2.3 Plant Machinery
2.4 Cost of Raw Material
2.5 Packaging
2.6 Transportation
2.7 Utilities
2.8 Manpower
2.9 Other Capital Investment
List of Figures and Tables
1. Global Nootropics Market: Key Industry Highlights, 2016 and 2026
2. Global Nootropics Historical Market: Breakup by Type (USD Billion), 2016-2020
3. Global Nootropics Market Forecast: Breakup by Type (USD Billion), 2021-2026
4. Global Nootropics Historical Market: Breakup by Distributional Channel (USD Billion), 2016-2020
5. Global Nootropics Market Forecast: Breakup by Distributional Channel (USD Billion), 2021-2026
6. Global Nootropics Historical Market: Breakup by Application (USD Billion), 2016-2020
7. Global Nootropics Market Forecast: Breakup by Application (USD Billion), 2021-2026
8. Global Nootropics Historical Market: Breakup by Region (USD Billion), 2016-2020
9. Global Nootropics Market Forecast: Breakup by Region (USD Billion), 2021-2026
10. North America Nootropics Historical Market: Breakup by Country (USD Billion), 2016-2020
11. North America Nootropics Market Forecast: Breakup by Country (USD Billion), 2021-2026
12. Europe Nootropics Historical Market: Breakup by Country (USD Billion), 2016-2020
13. Europe Nootropics Market Forecast: Breakup by Country (USD Billion), 2021-2026
14. Asia Pacific Nootropics Historical Market: Breakup by Country (USD Billion), 2016-2020
15. Asia Pacific Nootropics Market Forecast: Breakup by Country (USD Billion), 2021-2026
16. Latin America Nootropics Historical Market: Breakup by Country (USD Billion), 2016-2020
17. Latin America Nootropics Market Forecast: Breakup by Country (USD Billion), 2021-2026
18. Middle East and Africa Nootropics Historical Market: Breakup by Country (USD Billion), 2016-2020
19. Middle East and Africa Nootropics Market Forecast: Breakup by Country (USD Billion), 2021-2026
20. North America Historical Price Trends and Forecast 2016-2026
21. Europe Historical Price Trends and Forecast 2016-2026
22. Asia Pacific Historical Price Trends and Forecast 2016-2026
23. Latin America Historical Price Trends and Forecast 2016-2026
24. Middle East and Africa Historical Price Trends and Forecast 2016-2026
25. Global Nootropics Market Structure
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
RIGHT PEOPLE
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
RIGHT METHODOLOGY
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
RIGHT PRICE
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
RIGHT SUPPORT
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.